{"id":"W2129638180","doi":"10.1200/jco.2007.12.3083","title":"Phase II Study of Vandetanib or Placebo in Small-Cell Lung Cancer Patients After Complete or Partial Response to Induction Chemotherapy With or Without Radiation Therapy: National Cancer Institute of Canada Clinical Trials Group Study BR.20","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":196,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Vandetanib; Medicine; Internal medicine; Placebo; Gastroenterology; Oncology; Cancer; Phases of clinical research; Chemotherapy; Surgery; Pathology; Sorafenib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00251727,0.001934485,0.003430519,0.0004733038,0.0005223779,0.0009267966,0.001299276,0.00182899,0.00657947],"category_scores_gemma":[0.001822538,0.0008148522,0.001276888,0.0005198115,0.001348419,0.0006162949,0.0002969622,0.003176582,0.001265004],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001728168,"about_ca_system_score_gemma":0.003104483,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004841282,"about_ca_topic_score_gemma":0.01357731,"domain_scores_codex":[0.9992449,0.0004350517,0.00003067826,0.000103096,0.000073125,0.0001131224],"domain_scores_gemma":[0.9991755,0.0001536834,0.0001861787,0.00006043624,0.00005448776,0.0003697305],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9332426,0.023235,0.001415981,0.0009034162,0.001065303,0.00009250302,0.00009304484,0.000603024,0.006630928,0.0002062098,0.004280685,0.02823131],"study_design_scores_gemma":[0.9566301,0.04111402,0.001116296,0.00001204293,0.0001045705,0.00002297077,0.000007324604,0.0001784657,0.0001794116,0.00005517673,0.00057414,0.00000541807],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9542652,0.01055676,0.001643929,0.002355745,0.0009719497,0.02012797,0.004359681,0.0003218465,0.00539684],"genre_scores_gemma":[0.9599612,0.005497672,0.003641093,0.002851775,0.0005640213,0.01581163,0.002997988,0.00004927493,0.008625156],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00657947,"threshold_uncertainty_score":0.02201051,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2888795793822542,"score_gpt":0.5751775702922032,"score_spread":0.286297990909949,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}